Boston Scientific
@bostonsci
Followers
41K
Following
1K
Media
1K
Statuses
3K
Official news from Boston Scientific, a leading innovator of less invasive medical solutions that transform lives around the world. (NYSE: $BSX)
Boston, MA
Joined November 2010
RT @2026USAGames: The @2026USAGames announced today that @bostonsci will be an official sponsor of the USA Games, as well as the Official S….
2026specialolympicsusagames.org
Boston Scientific will serve as the Official Softball Sponsor of the Games
0
2
0
We’ve officially closed the acquisition of SoniVie, adding its investigational, ultrasound-based TIVUS™ system to our cardiovascular portfolio. This renal denervation technology holds promise for advancing hypertension care through a minimally invasive approach.
2
0
7
We’ve closed the acquisition of @InteraOncology, provider of the Intera 3000 Hepatic Artery Infusion Pump and floxuridine. We look forward to adding this technology to our portfolio and advancing treatment for patients with liver cancer.
1
2
13
ICYMI, here are a few key takeaways from our earnings announcement:
0
0
2
Tomorrow morning we’ll host a conference call & webcast to discuss Q1 2025 financial results. Tune in here: $BSX.
1
0
5
We have officially closed the acquisition of @BoltIVL. We look forward to advancing the intravascular lithotripsy (IVL) therapy developed by Bolt which will complement our cardiovascular portfolio by expanding treatment options for coronary and peripheral disease. $BSX
20
5
32
Further expansion of our cardiovascular portfolio includes today’s announcement that we’ve agreed to acquire SoniVie, developer of an intravascular ultrasound system designed to perform renal artery denervation for the treatment of hypertension.
4
5
26
ICYMI, here are a few key takeaways from our earnings announcement:
3
4
8
Boston Scientific announces results for Q4 & FY 2024: $BSX
0
0
7
Tomorrow morning we’ll host a conference call & webcast to discuss Q4 & FY 2024 financial results. Tune in here: $BSX.
1
1
4
We have officially closed the acquisition of @CortexEP. We look forward to advancing the OptiMap™ System developed by Cortex which complements our electrophysiology portfolio with a differentiated cardiac mapping offering to assist with complex atrial fibrillation cases.
2
5
18
“Everything we do is about making sure we advance care for patients around the world suffering from urological conditions,” says Meghan Scanlon, SVP and president, Urology. She shares how our acquisition of @axonics_mod will help us do just that.
news.bostonscientific.com
Learn how it will help us reach more women with overactive bladder and other debilitating urological conditions.
0
1
10
In an interview with @CNBC @jimcramer, CEO Mike Mahoney shares how breakthrough products are transforming healthcare and driving strong business performance: "We’re coming off a great 2023, better 2024 and we aim to have a terrific 2025 and beyond." #JPM25.
2
1
9
We’ve agreed to acquire @BoltIVL, developer of an intravascular lithotripsy (IVL) offering to treat coronary and peripheral disease, which will expand our cardiovascular portfolio with a complementary & differentiated calcium modification platform. $BSX
0
7
28
RT @BSCCardiology: CMS approved Transitional Pass-Through Payment (TPT) for AGENT DCB effective January 1, 2025. This will support coronary….
0
11
0
We are guided by our commitment to enhance the quality of patient care. Every success story shared at our Everyone Makes an Impact (EMAI) events begins with our dedicated employees who make a difference in millions of lives. #AdvancingTogether
4
1
10